Masters R, Taaning E
National Blood Service, Brentwood Centre, Brentwood, UK.
Vox Sang. 1998;75(3):242-6.
In three cases of platelet alloimmunisation, a platelet-specific alloantibody was detected which could not be classified within the known human platelet alloantigen or HLA systems. The first case was of a family in which two siblings suffered neonatal alloimmune thrombocytopenia at birth. In the second case, the newborn was suffering from phocomelia with hypoplastic thrombocytopenia. The third case was a male who became refractory to transfusions of HLA-matched platelets after a related bone marrow transplantation.
The serum samples were investigated by: enzyme-linked immunosorbent assay, platelet suspension immunofluorescence test (PSIFT), monoclonal antibody immobilisation of platelet antigens assay (MAIPA), and by the lymphocytotoxicity test.
The antibody gave positive reactions with 26% of normal donor platelets. Surprisingly, no platelet-specific antibody was detected by PSIFT or by MAIPA and there was no evidence found to support classifying the antibody within the HLA system.
The reactivity pattern of the antibody detected and the clinical presentation of the three cases described, strongly suggest the presence of an additional platelet-specific alloantigen system.
在三例血小板同种免疫病例中,检测到一种血小板特异性同种抗体,该抗体无法归类于已知的人类血小板同种抗原或HLA系统。第一例是一个家庭,其中两个兄弟姐妹出生时患有新生儿同种免疫性血小板减少症。第二例中,新生儿患有短肢畸形伴血小板减少。第三例是一名男性,在进行相关骨髓移植后,对HLA匹配的血小板输注产生了耐药性。
采用酶联免疫吸附测定、血小板悬液免疫荧光试验(PSIFT)、血小板抗原单克隆抗体固定试验(MAIPA)以及淋巴细胞毒性试验对血清样本进行研究。
该抗体与26%的正常供体血小板呈阳性反应。令人惊讶的是,PSIFT或MAIPA未检测到血小板特异性抗体,也没有证据支持将该抗体归类于HLA系统。
检测到的抗体反应模式以及所描述的三例病例的临床表现,强烈提示存在一个额外的血小板特异性同种抗原系统。